- 专利标题: Synergistic compositions
-
申请号: US15962498申请日: 2018-04-25
-
公开(公告)号: US10315993B2公开(公告)日: 2019-06-11
- 发明人: Mukul R. Jain , Suresh Giri , Himanshu M. Kothari , Kaushik Banerjee , Rashmikant Kachhiya
- 申请人: Cadila Healthcare Limited
- 申请人地址: IN Ahmedabad, Gujarat
- 专利权人: Cadila Healthcare Limited
- 当前专利权人: Cadila Healthcare Limited
- 当前专利权人地址: IN Ahmedabad, Gujarat
- 代理机构: Goodwin Procter LLP
- 优先权: IN2276/MUM/2013 20130705
- 主分类号: C07D207/333
- IPC分类号: C07D207/333 ; C07C215/40 ; A61K38/26 ; C07D295/027 ; A61K31/4985 ; C07C215/10 ; C07C217/60 ; C07C211/51 ; C07D233/58 ; A61K31/4015 ; C07C211/11 ; C07C215/12 ; C07C211/30 ; C07C229/26 ; A61K31/40 ; A61K31/155 ; C07C211/27 ; A61K31/64 ; A61K31/505 ; C07C211/35 ; A61K45/06 ; C07C279/14
摘要:
The present invention describes a synergistic composition comprising of one or more statins, or one or more dipeptidyl peptidase IV (DPP IV) inhibitor or one or more biguanide antihyperglycaemic agent and a PPAR agonist of formula (Ia) for the treatment of diabetes, especially non-insulin dependent diabetes (NIDDM) or Type 2 diabetes and conditions associated with diabetes mellitus and to compositions suitable for use in such method. The invention also describes the preparation of such compositions. The present invention also relates to certain novel salts of the PPAR agonist of formula (I), processes for the preparation of these novel salts and use thereof.
公开/授权文献
- US20180305311A1 SYNERGISTIC COMPOSITIONS 公开/授权日:2018-10-25
信息查询